Abstract
An improved RP- HPLC method with PDA detection has been developed and validated for the simultaneous estimation of artemisinin and dexamethasone in ocular nanodispersion formulations and it has been successfully adopted to check the ex-vivo corneal transport. The chromatographic separation was achieved using phenomenex C18 column (250 × 4.6 mm, 5 µm) analytical column and the mobile phase consisting of acetonitrile: (methanol : water, 4: 6) mixture at the ratio of 45: 55, v/v at a flow rate of 1.0 mL/min and injection volume of 200 µl. The column temperature was maintained at 50°C. The UV detection was carried out at 219 nm using photodiode array detector. The retention times of dexamethasone and artemisinin were found to be 4.5 and 7.9 minutes respectively. Artemisinin and dexamethasone calibration curves were found to be linear with correlation coefficient of 0.9617 and 0.9954 respectively at a dynamic concentration ranging from 250ng/mL to 1250 ng/mL. Recovery was between the ranges of 98.9% - 116.8% for both artemisinin and dexamethasone. The developed method is very selective as both peaks were well separated with a short analysis time of 10 minutes and does not require any preliminary treatment of sample.
Keywords: Artemisinin, dexamethasone, RP- HPLC, quantification, nanodispersions.
Current Pharmaceutical Analysis
Title:Simultaneous Estimation of Artemisinin and Dexamethasone in Nanodispersions and Assessment of Ex-vivo Corneal Transport Study by RP- HPLC
Volume: 10 Issue: 1
Author(s): Chandrasekar Ponnusamy, Venkateshwaran Krishnaswami, Abimanyu Sugumaran and Subramanian Natesan
Affiliation:
Keywords: Artemisinin, dexamethasone, RP- HPLC, quantification, nanodispersions.
Abstract: An improved RP- HPLC method with PDA detection has been developed and validated for the simultaneous estimation of artemisinin and dexamethasone in ocular nanodispersion formulations and it has been successfully adopted to check the ex-vivo corneal transport. The chromatographic separation was achieved using phenomenex C18 column (250 × 4.6 mm, 5 µm) analytical column and the mobile phase consisting of acetonitrile: (methanol : water, 4: 6) mixture at the ratio of 45: 55, v/v at a flow rate of 1.0 mL/min and injection volume of 200 µl. The column temperature was maintained at 50°C. The UV detection was carried out at 219 nm using photodiode array detector. The retention times of dexamethasone and artemisinin were found to be 4.5 and 7.9 minutes respectively. Artemisinin and dexamethasone calibration curves were found to be linear with correlation coefficient of 0.9617 and 0.9954 respectively at a dynamic concentration ranging from 250ng/mL to 1250 ng/mL. Recovery was between the ranges of 98.9% - 116.8% for both artemisinin and dexamethasone. The developed method is very selective as both peaks were well separated with a short analysis time of 10 minutes and does not require any preliminary treatment of sample.
Export Options
About this article
Cite this article as:
Ponnusamy Chandrasekar, Krishnaswami Venkateshwaran, Sugumaran Abimanyu and Natesan Subramanian, Simultaneous Estimation of Artemisinin and Dexamethasone in Nanodispersions and Assessment of Ex-vivo Corneal Transport Study by RP- HPLC, Current Pharmaceutical Analysis 2014; 10 (1) . https://dx.doi.org/10.2174/157341291001140102111031
DOI https://dx.doi.org/10.2174/157341291001140102111031 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiviral Activities of Human Host Defense Peptides
Current Medicinal Chemistry Curcumin and Curcumin-like Molecules: From Spice to Drugs
Current Medicinal Chemistry Crocetin as an Active Secondary Metabolite of Saffron Stigma and Anticancer Effects
Current Cancer Therapy Reviews SCF E3 Ubiquitin Ligases as Anticancer Targets
Current Cancer Drug Targets High-Risk HPV/ErbB-2 Interaction on E-Cadherin/Catenin Regulation in Human Carcinogenesis
Current Pharmaceutical Design Molecular Pathways Linking Inflammation and Cancer
Current Molecular Medicine A Review of Therapeutic Effects of Curcumin
Current Pharmaceutical Design Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk
Anti-Cancer Agents in Medicinal Chemistry The Epidemiology and Health Effects of Tobacco Use
Current Pediatric Reviews The Role of Flavonoids in Inhibiting IL-6 and Inflammatory Arthritis
Current Topics in Medicinal Chemistry What they are, How they Work and Why they do What they do? The Story of SV40-derived Gene Therapy Vectors and What They Have to Offer
Current Gene Therapy Involvement of Potassium and Chloride Channels and Other Transporters in Volume Regulation by Spermatozoa
Current Pharmaceutical Design Transductional and Transcriptional Targeting of Adenovirus for Clinical Applications
Current Gene Therapy The Role of Carrier Geometry in Overcoming Biological Barriers to Drug Delivery
Current Pharmaceutical Design Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Combination of DC Vaccine and Conventional Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities
Current Cancer Drug Targets Phenanthridine Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Design, Synthesis and Biological Evaluation
Current Computer-Aided Drug Design